As of 10:23am ET
| +0.0249 / +4.29%|
The 2 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 1.80, with a high estimate of 3.00 and a low estimate of 0.60. The median estimate represents a +197.52% increase from the last price of 0.61.
The current consensus among 2 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.